GGrantIndex
Sort

15,273 grants matching antimicrobial resistance

Structural and functional studies of the mycobacterial transcription cycle

$358,826
Elizabeth A Campbell · Rockefeller University · R35 · FY2024 · GM

Temporal and spatial expression of regulators affecting Escherichia coli biofilm

$358,750
Birgit Magdalene Pruess · North Dakota State University · R15 · FY2011 · AI

Development of antibacterial agents and materials

$358,668
Joel Schneider · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Oxarane-Acrylate System to Double the Clinical Service Life of Restorative Resins

$358,585
H. Ralph Rawls · University Of Texas Hlth Science Center · U01 · FY2016 · DE

Regulating Cathelicidin Expression for Disease Therapy

$358,556
Adrian Friedrich Gombart · Oregon State University · R01 · FY2009 · AI

E. coli invasion of brain endothelial cells

$358,502
Kwang S Kim · Johns Hopkins University · R01 · FY2007 · NS

E. coli invasion of brain endothelial cells

$358,502
Kwang S Kim · Johns Hopkins University · R01 · FY2008 · NS

Collaborative Research: NSF-BSF: CIF: Small: An Information Theory for Out-of-Order Data: Applications in Genomics, Molecular Storage, and Beyond

$358,400
Ilan Shomorony · University Of Illinois At Urbana-Champaign · · FY2025 · CSE

Rapid Antimicrobial Susceptibility Test Cartridge for Resource-Limited Settings

$358,327
Vincent Jen-Jr Gau · Genefluidics, Inc. · R43 · FY2011 · AI

B-lactam mediated SOS response and expression of resistance in clinical MRSA

$358,281
Adriana E Rosato · Methodist Hospital Research Institute · R01 · FY2013 · AI

Novel Azole Resistance Mechanisms in Candida albicans

$358,200
P David Rogers · University Of Tennessee Health Sci Ctr · R01 · FY2015 · AI

Novel Azole Resistance Mechanisms in Candida albicans

$358,200
P David Rogers · University Of Tennessee Health Sci Ctr · R01 · FY2016 · AI

Synthetic Studies on the Antibiotic Saccharomicin B.

$358,159
Clay Samuel Bennett · Tufts University Medford · R01 · FY2018 · GM

Synthetic Studies on the Antibiotic Saccharomicin B.

$358,159
Clay Samuel Bennett · Tufts University Medford · R01 · FY2017 · GM

Synthetic Studies on the Antibiotic Saccharomicin B.

$358,159
Clay Samuel Bennett · Tufts University Medford · R01 · FY2015 · GM

Synthetic Studies on the Antibiotic Saccharomicin B.

$358,159
Clay Samuel Bennett · Tufts University Medford · R01 · FY2016 · GM

PHOP REGULON AND SALMONELLA VIRULENCE

$358,152
Samuel I. Miller · University Of Washington · R01 · FY2010 · AI

Regulation of IFN-g-induced Innate Immunity by LRG-47

$358,113
Gregory A Taylor · Duke University · R01 · FY2008 · AI

Ampetoids as Biostable Functional Mimics of Antimicrobial Peptides

$358,110
Annelise Emily Barron · Stanford University · R01 · FY2008 · AI

Nanomechanics of bacterial adhesion

$358,061
Julio M Fernandez · Columbia Univ New York Morningside · R01 · FY2017 · GM

Project 3: Molecular Risk Stratification of Gastric Precancerous Lesions

$357,876
Joo H Hwang · Stanford University · P01 · FY2024 · CA

Chemoprotection Against Aminoglycoside-Induced Ototoxicity

$357,854
Julian A Simon · Fred Hutchinson Cancer Research Center · R01 · FY2010 · DC

PGA exopolysaccharide in biofilm formation and pathogenicity of Aggregatibacter a

$357,750
Narayanan Ramasubbu · Rbhs-School Of Dental Medicine · R01 · FY2016 · DE

PGA exopolysaccharide in biofilm formation and pathogenicity of Aggregatibacter a

$357,750
Narayanan Ramasubbu · Rbhs-School Of Dental Medicine · R01 · FY2014 · DE

PGA exopolysaccharide in biofilm formation and pathogenicity of Aggregatibacter a

$357,750
Narayanan Ramasubbu · Rbhs-School Of Dental Medicine · R01 · FY2015 · DE